The melanoma differentiation-associated gene-7 (mda-7), cloned from a human melanoma cell line H0-1, is known to induce tumor cell-selective growth inhibition in breast cancer cells in vitro and loss of tumorigenicity ex vivo. Yet, the mechanisms underlying these effects are still unknown. Therefore, we investigated these mechanisms on the molecular level in human non-small cell lung carcinoma (NSCLC) cells in vitro. Overexpression of mda-7 protein by Ad-mda-7 significantly suppressed proliferation and induced G2/M cell cycle arrest in wild-type p53 (A549, H460), and p53-null (H1299) non-small cell lung cancer cell lines, but not in normal human lung fibroblast (NHLF) cells. p53, Bax,
Introduction
Recently, the melanoma differentiation-associated gene-7 (mda-7) has gained attention as a potential tumor suppressor. Its cDNA was originally isolated by subtraction hybridization from a human melanoma cell line (H0-1) that was induced to differentiate terminally by treatment with recombinant human fibroblast interferon-beta (IFN-␤) plus mezerein (MEZ). The mda-7 gene encodes a protein of 206 amino acids with a predicted molecular mass of 23.8 kDa.
1 Several other melanoma differentiationassociated genes have also been isolated using this technique, including the cyclin-dependent kinase inhibitor p21 (mda-6) 2 and mda-9.
3 mda-7 mRNA levels are higher in actively proliferating normal melanocytes than in melanoma cells, and the level of mda-7 expression is inversely related to melanoma progression, 1 suggesting that mda-7 is a novel tumor suppressor gene whose expression must be inhibited for tumor progression to occur.
Indeed, by using a colony formation assay, Jiang et al 4 found that mda-7 is a potent growth-suppression gene in cancer cells of diverse origin. Furthermore, Su et al 5 demonstrated induction of apoptosis by overexpression of mda-7 in breast cancer cell lines in vitro and inhibition and Bak protein expression was up-regulated in wild-type p53 tumor cell lines, but not in p53-null cells, suggesting that an intact p53 pathway was required for Bax and Bak induction. However, in all three cancer cell lines tested, activation of the caspase cascade and cleavage of poly(ADP-ribose) polymerase (PARP) appeared to be independent of the p53 mutational status. Together, these results suggest that apoptosis may be induced via multiple pathways by Ad-mda-7 in lung cancer cells and that Ad-mda-7 has the potential to become a novel therapeutic for clinical cancer gene therapy. Gene Therapy (2000) 7, 2051-2057.
of tumor formation of MCF-7 xenograft following mda-7 expression. However, when mda-7 was overexpressed in normal human cells (human mammary epithelial cells and HBL-100), only limited cytotoxic effects were seen. In addition, Bax protein expression was up-regulated following overexpression of mda-7 in breast cancer cell lines T47D and MCF-7. This implied that the Bax protein may be involved in the apoptotic pathway induced by mda-7, an especially interesting hypothesis since Bax and other Bcl-2 protein family genes are known to be key regulators of apoptosis and important determinants of cell fate. 6 Previous studies have defined mda-7 as a novel tumor suppressor gene having an antitumor activity in vitro and suggested that it inhibits a diverse number of cancers. However, the functions of the mda-7 gene and its downstream pathways remain unknown. Consequently, to understand better how mda-7 functions and to help broaden the scope of current anticancer gene therapy strategies, [7] [8] [9] we tested the antitumor effects of a novel adenoviral vector carrying the mda-7 gene (Admda-7) on non-small cell lung cancer lines and investigated the underlying mechanisms of tumor killing.
In the present study, we demonstrate Ad-mda-7 may function by triggering more than one apoptotic pathway to kill both wild-type p53-expressing (p53 wt ) and p53-deleted (p53 null ) lung cancer cell lines.
Results mda-7 Expression following Ad-mda-7 infection in lung tumor and normal fibroblast cells To detect mda-7 expression in cells, human lung cancer cells (A549, H460 and H1299) and normal human fibroblast (NHLF) cells were infected with Ad-mda-7. Fortyeight hours later, cells were fixed and stained with antimda-7 antibody. Uninfected cells stained with the same antibody served as controls. High levels of mda-7 expression were observed primarily in the cytoplasm and perinuclei of both tumor cells and normal cells but not in the nucleus. mda-7 Expression was not observed in uninfected control cells (Figure 1 ).
Overexpression of mda-7 results in inhibition of cell proliferation and G2/M cell cycle arrest A549, H1299, H460 and NHLF cells were grown in sixwell plates ( 
Overexpression of mda-7 induces apoptosis in tumor cells but not in normal fibroblasts
Following infection of Ad-mda-7, tumor cells (A549, H460 and H1299) and normal cells (NHLF) were analyzed for apoptotic change by annexin V assay and TUNEL staining. Forty-eight hours after Ad-mda-7 infection, an increase in annexin V-positive cells, an indicator of initial apoptotic changes, was observed in the three tumor cell lines tested by FACS analysis. However, no changes were observed in cells infected with Ad-Luc or mock. In contrast, normal cells infected with either Admda-7 or Ad-Luc did not demonstrate any change in the number of annexin V-positive cells (Figure 3a ). To confirm these results further, TUNEL staining was per- 
infected () or PBStreated cells (᭜). However, NHLF cells were not growth inhibited by both Ad-Luc and Ad-mda-7 when compared with PBS treated controls. (b) Cell-cycle analysis of A549 and H1299 tumor cells at 48 h after treatment with Ad-mda-7 (í), Ad-Luc (), or PBS (a). G2/M arrest was observed in both A549 and H1299 cells infected with Ad-mda-7.
formed 72 h after infection. Tumor cells but not normal cells were observed to undergo apoptosis following mda-7 infection. No changes were observed in any of the cell lines infected with Ad-Luc (Figure 3b ).
Expression of mda-7 results in up-regulation of proapoptotic proteins p53, Bax and Bak in p53 wt tumor cells Cells wild-type for p53 (A549, H460, and NHLF) and null for p53 (H1299) were infected with Ad-mda-7 and AdLuc. Cells were harvested at 24, 48 and 72 h after infection and extracts were prepared for Western blot analysis. Extracts from mock-infected cells were used as an additional control. mda-7 Protein expression was detected in all of the Ad-mda-7-infected cell lines but not in any mock-infected controls or Ad-Luc-infected cells. Further analysis of these cell extracts demonstrated up-
Figure 3 mda-7-Induced apoptosis in tumor cells but not normal cells. (a) Tumor cells (A549, H460 and H1299) and NHLF cells were infected with Ad-mda-7 or Ad-Luc, or treated with PBS. Forty-eight hours later cells were analyzed for apoptosis by annexin V assay. In the three tumor cell lines, Ad-mda-7 infection (í) induced apparent increase of annexin V-positive cells as compared with PBS (a) and Ad-Luc () treated controls, while no increase in positive cells was observed in NHLF cells after either vector infection. (b) Seventy-two hours after infection, cells were analyzed by TUNEL staining. Apoptotic cell death was observed in tumor cells but not in NHLF cells. Arrows indicate cells undergoing apoptotic cell death.
regulation of protein levels of p53 (up to 11.0-fold over control infected with PBS and 5.4-fold over luciferase infected control), Bax (up to 2.2-fold over PBS control and 2.7-fold over luciferase), and Bak (up to 2.0-fold over PBS and 2.5-fold over luciferase) in p53 wild-type A549 and H460 tumor cells after Ad-mda-7 infection. As expected, no expression or modulation of p53 was seen in p53-deleted H1299 cells. Moreover, no change in Bax or Bak protein levels was observed in H1299 cells. In NHLF cells, p53, Bax and Bak protein levels were not changed following mda-7 expression (Figure 4 ). The expression level of Bcl-2 was not significantly changed in any of the three tumor cell lines analyzed (data not shown).
Caspase cascade activation and cleavage of PARP following mda-7 expression Since mda-7 expression results in up-regulation of proapoptotic genes and induces apoptosis in tumor cells, the activation of caspases was studied by Western blot analysis. These analyses demonstrated activation of a caspase cascade including cleavage of caspase-9 and caspase-3 at 48 h after Ad-mda-7 infection in A549 and H460 cells and at 72 h after infection in H1299 cells. Cleavage of PARP, a substrate for the caspases, was observed at 48 h in A549 and H460 cells and at 72 h in H1299 cells. Caspase-9, caspase-3 and PARP were not cleaved in NHLF cells ( Figure 5 ).
Apoptosis induced by Ad-mda-7 was inhibited by pancaspase inhibitor To determine the role of caspase in mda-7-mediated tumor killing, H1299 cells were infected with Ad-mda-7 or Ad-Luc in the presence or absence of pancaspase inhibitor Z-VAD.FMK (Calbiochem, San Diego, CA, USA) 10, 11 containing culture medium (1.0 g/ml).
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Seventy-two hours after infection cells were harvested and analyzed for annexin V, an early activator of apoptosis, by flow cytometry. Apoptosis induced by Admda-7 was 48% inhibited by Z-VAD.FMK, while no inhibition was observed in Ad-Luc-infected cells ( Figure 6 ).
Discussion
As the development of gene therapies for cancer continues, the list of novel therapeutic agents grows. Among these agents are those for targeting specific molecular lesions or pathways unique to tumor cells and maximizing anticancer efficacy. Recently, one such agent, mda-7, has been shown to inhibit growth and induce apoptosis upon its transfer into breast cancer cells. 5 The mechanisms underlying this anticancer activity of the mda-7 gene are unknown; however, induction of apoptosis by Ad-mda-7 in a p53-independent manner has been demonstrated. 5 In the present study, we extended these studies and evaluated Ad-mda-7 as an antitumor agent in lung cancer.
In the present study, enforced expression of mda-7 by Ad-mda-7 infection of lung cancer cell lines significantly suppressed cell proliferation by utilizing a pathway mediated via G2/M cell cycle arrest and resulting in apoptosis. It is unknown whether mda-7 induces G2/M cell cycle arrest directly or indirectly via some alternative mechanisms. One possibility is that mda-7 and p21 coordinately affect cell cycle kinetics. This has been suggested by the fact that the technique used to isolate mda-7 was previously used to clone mda-6, which was later identified as the p21 gene from terminally differentiated H0-1 cells. 2 Our analysis of the effects of mda-7 on normal lung fibroblast cells demonstrated that Ad-mda-7 infection did not inhibit cell growth in NHLF cells. The differ- 
Figure 5 Mediation of apoptosis by mda-7 via caspase activation. A549, H460, H1299, and NHLF cells were infected with Ad-mda-7 or Ad-Luc. Proteins were then extracted from cells and separated by SDS-PAGE. Activation of caspase-9 and caspase-3 and cleavage of PARP, a caspase substrate, as indicated by the presence of a cleaved product, were observed at 48 h after infection with Ad-mda-7 in A549 and H460 cells and after 72 h in H1299 cells. Neither activation of caspase-9 and caspase-3 nor cleavage of PARP was detectable in any Ad-Luc-infected group. In NHLF cells activation of caspase-9 and caspase-3, or cleavage of PARP was not seen.

Figure 6 Inhibition of apoptosis by pancaspase inhibitor z-VAD-FMK. H1299 cells were infected with Ad-mda-7 or Ad-Luc under the conditions of medium with or without pancaspase inhibitor z-VAD.FMK (1.0 g/ml). Seventy-two hours after infection, analysis of cells for apoptosis with annexin V assay kit demonstrated a 48% inhibition in apoptosis in Ad-mda-7 infected cells in the presence of z-VAD.FMK.
ences in toxicity to mda-7 between normal cells and tumor cells remain unknown.
To understand further the underlying mechanism of tumor killing mediated by mda-7 expression, we analyzed the effects of such expression on some of the known proapoptotic genes (ie p53, Bax and Bak). Following infection with Ad-mda-7, expression of the tumor suppressor gene p53, whose expression has been shown to induce apoptosis, 12 increased in p53 wt , A549 and H460 tumor cells, but was undetectable in p53 null H1299 cells. Although p53 expression seemed slightly up-regulated in Ad-Luc-infected p53 wt cells (A549 and H460) as compared with PBS control, a 5.4-fold increase in p53 expression was observed in Ad-mda-7-infected tumor cells when compared with Ad-Luc-infected cells. These results suggest p53 up-regulation by Ad-mda-7 is specific and not due to nonspecific viral infection. 13 While the molecular mechanism responsible for up-regulation of p53 is not well understood, it is believed that most of it is due to post-transcriptional regulation via stabilization of p53 protein. 14 In light of the recent demonstration of Bax upregulation in Ad-mda-7-infected breast cancer cell lines TD47 and MCF-7, 5 we examined our lung tumor cell lines of choice for Bax and Bak expression and observed a modest up-regulation of Bax and Bak following Ad-mda-7 infection in p53 wild-type lung cancer cell lines (A549 and H460). This observation is consistent with the p53-dependent pathway of apoptosis, wherein Bax is directly transcriptionally induced by p53, resulting in the release of cytochrome c from the mitochondria and activation of the downstream caspase cascade. 14, 15 Together, these results suggest that up-regulation of Bax and Bak protein following mda-7 expression is dependent on a functional wild-type p53 gene and that the mda-7 and p53 pathways may converge on common downstream apoptotic effectors. This hypothesis, in turn, is supported by a report that Ad-p53-mediated wild-type p53 transfer up-regulated Bax and Bak protein expression in p53-mutated and p53-deficient lung cancer cell lines. 16 However, since we observed no increase in the levels of Bax and Bak protein in p53-deficient H1299 cells undergoing apoptosis, we concluded that mda-7-mediated tumor cell killing occurs Gene Therapy independently of p53, Bax and Bak expression. It might be possible to say that the main apoptotic pathway by Ad-mda-7 infection is independent of the p53 pathway and that the p53-dependent pathway seen in p53 wt tumor cells additionally participates in apoptotic mechanisms thereby enhancing the apoptotic effects of mda-7.
Additionally, we investigated the effects of mda-7 overexpression on Bax protein-deficient and p53-mutated human prostate cancer cell line DU145 17 and found that overexpression of mda-7 induced apoptosis and activated a common caspase cascade including cleavage of caspase-9 and caspase-3. No change in p53 and Bak protein levels was seen (data not shown). Together, these results imply that the mda-7-mediated apoptotic pathway is independent of Bax status.
Moreover, Ad-mda-7 infection on H1299 cells and Baxdeficient DU145 cells activated caspase-9, a target of cytochrome c and Apaf-1 complex and a putative initiator of caspase activity. 18 No differences were observed in apoptotic pathways downstream of mitochondrial activation between cells that have an abnormality in either p53 status or Bax status and cells that carry the wild types of these genes. However, activation of the caspase cascade was detected at 48 h after infection in A549 and H460 (p53 wt ) versus 72 h in H1299 (p53 null ) and DU145 (p53 mut ) cells, suggesting that the difference in the ability of their apoptotic signaling pathways to reach the point of mitochondrial release of cytochrome c may be responsible for this delay. To understand further the role of caspases in Ad-mda-7-induced cell killing, H1299 cells when infected with Ad-mda-7 in the presence of pan-caspase inhibitor Z-VAD.FMK, a broad spectrum cell-permeable caspase inhibitor, resulted in inhibition of apoptosis. This observation suggests caspases are required for inducing apoptosis mediated by mda-7. The inability to achieve complete inhibition of apoptosis might be due either to degradation of the inhibitor or to the presence of other caspases that are yet to be identified. Meanwhile, the key molecules underlying the selection of apoptotic pathways versus cell cycle arrest, the mechanism of cell cycle arrest, and the mechanism of the p53-independent apoptotic pathway still remain unresolved. Furthermore, the differences in response against the apoptotic signal between tumor cells and normal cells are not well known. However, these results imply there are differences in the mechanisms to elicit the apoptotic pathway. At least, mda-7 expression mediated by adenovirus does not trigger keys to activate the apoptotic pathway in NHLF cells.
In the clinical setting, tumors may carry a diverse array of mutated tumor suppressor genes, oncogenic genes, or both. Therefore, our finding that Ad-mda-7 was able to induce apoptosis in a series of lung cancer cell lines that utilize a variety of mutated apoptotic signaling pathways has clear clinical implications. Because of its broad spectrum of activity, Ad-mda-7 is a likely prototype for a novel class of tumor suppressor genes with the potential to become new therapeutic agents for clinical cancer gene therapy and the potential to extend the repertoire of antitumor gene therapy agents for treating lung cancer.
Materials and methods
Cell culture
Human non-small cell lung carcinoma (NSCLC) cell lines A549 (adenocarcinoma) and H1299 (large cell carcinoma) were gifts from Dr A Gazdar and Dr JD Minna (University of Texas South Western Medical Center, Dallas, Texas), H460 (large cell carcinoma) was obtained from the American Type Culture Collection (Bethesda, MD, USA). The p53 status for A549 and H460 is wild type (p53 wt ) and for H1299 is null (p53 null ). All cancer cells were maintained in RPMI 1640 medium containing 10% fetal bovine serum, antibiotics and l-glutamine. Normal human lung fibroblast (NHLF) cells were obtained from Clonetics (Walkersville, MD, USA) and maintained according to the manufacturer's instructions. All cells were verified to be free of mycoplasma before the start of the experiments and were used in the log phase of growth.
Construction of recombinant adenoviral vector
Replication-deficient human type 5 adenoviral (Ad5) vectors carrying either the mda-7 gene, or a luciferase gene linked to an internal CMV-IE promoter and followed by SV40 polyadenylation (pA) signal were constructed (they are referred to herein as Ad-mda-7 and Ad-Luc, respectively). 4 Viruses were propagated in 293 cells and purified by chromatography. 
Gene transfer
Immunohistochemical staining
Immunohistochemical staining was carried out on virusinfected cells to determine mda-7 protein expression. Briefly, cells were seeded in two-well chamber slides at a density of 1 × 10 5 cells per well and infected with Admda-7 or Ad-Luc. Forty-eight hours after infection, cells were fixed in a 4% formalin solution. After blocking of endogenous peroxidase activity with 0.3% H 2 O 2 in methanol, cells were incubated with normal goat serum. Following incubation, slides were treated with rabbit polyclonal anti-mda-7 antibody (1:5000 dilution). After incubation with an anti-rabbit secondary antibody (ABC kit, Vector Laboratories, Burlingame, CA, USA), expression of mda-7 in cells was detected with DAB (Sigma, St Louis, MO, USA) by enhancement with an avidin-biotin reaction ABC kit (Vector Laboratories).
Determination of cell growth rate
Cancer and normal cell lines used in this study were plated in six-well tissue culture dishes at a density of 5 × 10 4 cells per well. Tumor cells and NHLF cells were then infected with Ad-mda-7 or Ad-Luc, or treated with PBS (as a negative control). Cells in each treatment group were plated in triplicate and cultured for 5 days. Then, at designated time-points, cells were harvested by trypsinization, and stained with trypan blue (GIBCO BRL, Grand Island, NY, USA), to reveal dead cells. Viable cells were then counted on a hemocytometer.
Cell cycle analysis
Cells were seeded in 10-cm culture dishes (1 × 10 5 cells per dish) and infected with Ad-mda-7 or Ad-Luc, or treated with PBS. Forty-eight hours after infection, cells were harvested by trypsinization, fixed with 70% ethanol, and resuspended in 500 l of a propidium iodide (PI) solution (Boehringer Mannheim, Indianapolis, IN, USA) (5 g/ml PI and 10 g/ml RNase). DNA contents and cell cycle phases were analyzed using a fluorescence-activated cell sorter (EPICS XL-MCL; Beckman Coulter, Fullerton, CA, USA).
Annexin V assay Annexin V staining was performed as described. 10 Briefly, cells were seeded in 60-mm culture dishes (5 × 10 5 cells per dish), treated with PBS, Ad-mda-7 or AdLuc and harvested by trypsinization 48 h after infection. Cells were washed with PBS and stained with annexin V (PharMingen, San Diego, CA, USA) according to the manufacturer's instructions and percentages of annexin V-positive cells were analyzed by flow cytometry.
TUNEL staining
Cells were seeded in two-well chamber slides at a density of 1 × 10 5 cells per well and infected with Ad-mda-7 or Ad-Luc. Seventy-two hours after infection, cells were analyzed for apoptosis by terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick-end labeling (TUNEL) staining with terminal transferase (Boehringer Mannheim).
Western blot analysis
To determine the regulation of various proapoptotic genes (p53, Bax and Bak) and activation of caspases following mda-7 expression, Western blot analysis was performed as described previously. 19 Briefly, cells were harvested by trypsinization and resuspended in lysis buffer (62.5 mm Tris-HCl, 2% SDS, 10% glycerol, 4 m urea). Protein samples (50 g) were each diluted into a 20 l solution of lysis buffer and 5% 2-mercaptoethanol (Bio-Rad Laboratories, Hercules, CA, USA) and heated in a water bath at 95°C for 5 min. Then, protein extracts were separated by 10% SDS-PAGE in a vertical-slab gel electrophoresis cell (Bio-Rad). Next, the separated proteins were transferred from gel to nitrocellulose membrane (Hybond-ECL; Amersham Pharmacia Biotech, Buckinghamshire, UK) and then blocked in a blocking solution (5% dry milk and 0.3% Tween 20 in PBS) for 1 h. Then, membranes were incubated with the primary antibodies p53 (1:1000), Bax (1:500), Bak (1:500), Bcl-2 (1:300), caspase-9 (1:2000), caspase-3 (1:1000), PARP (1:250), and ␤-actin (1:10000). (p53, Bax, Bak and Bcl-2 antibodies are from Santa Cruz Biotechnology (Santa Cruz, CA, USA); caspase-9, caspase-3, and PARP antibodies from PharMingen; and ␤-actin antibody from Sigma.) The membranes were then incubated with horseradish peroxidaselabeled secondary antibodies (Amersham). Finally, the proteins were visualized on enhanced chemiluminescence film (Hyperfilm; Amersham) by application of Amersham's Enhanced Chemiluminescence Western Blotting Detection System.
